These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15994946)

  • 1. Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model.
    Xu L; Tong R; Cochran DM; Jain RK
    Cancer Res; 2005 Jul; 65(13):5711-9. PubMed ID: 15994946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
    Zhang H; Sun JD; Yan LJ; Zhao XP
    Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
    Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
    Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of platelet-derived growth factor-B on renal cell carcinoma growth and progression.
    Wang W; Qi L; Tan M; Zhang Z; Du J; Wei X; Yao X
    Urol Oncol; 2015 Apr; 33(4):168.e17-27. PubMed ID: 25766258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of platelet derived growth factor-B and its receptor expression on the proliferation of renal cell carcinoma ACHN cells].
    Wang W; Zhang Z; Wang S; Du J; Yao X
    Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):170-4. PubMed ID: 25975783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.
    Kim R; Emi M; Arihiro K; Tanabe K; Uchida Y; Toge T
    Cancer; 2005 May; 103(9):1800-9. PubMed ID: 15786421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-derived growth factor-D modulates extracellular matrix homeostasis and remodeling through TIMP-1 induction and attenuation of MMP-2 and MMP-9 gelatinase activities.
    Borkham-Kamphorst E; Alexi P; Tihaa L; Haas U; Weiskirchen R
    Biochem Biophys Res Commun; 2015 Feb; 457(3):307-13. PubMed ID: 25576870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
    Hwang RF; Yokoi K; Bucana CD; Tsan R; Killion JJ; Evans DB; Fidler IJ
    Clin Cancer Res; 2003 Dec; 9(17):6534-44. PubMed ID: 14695158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways.
    Ahmad A; Wang Z; Kong D; Ali R; Ali S; Banerjee S; Sarkar FH
    Breast Cancer Res Treat; 2011 Feb; 126(1):15-25. PubMed ID: 20379844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines.
    Apte SM; Bucana CD; Killion JJ; Gershenson DM; Fidler IJ
    Gynecol Oncol; 2004 Apr; 93(1):78-86. PubMed ID: 15047217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDGF-D signaling: a novel target in cancer therapy.
    Wang Z; Kong D; Li Y; Sarkar FH
    Curr Drug Targets; 2009 Jan; 10(1):38-41. PubMed ID: 19149534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancer.
    Reinmuth N; Liersch R; Raedel M; Fehrmann F; Fehrmann N; Bayer M; Schwoeppe C; Kessler T; Berdel W; Thomas M; Mesters RM
    Int J Cancer; 2009 Apr; 124(7):1535-44. PubMed ID: 19115205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
    Uren A; Merchant MS; Sun CJ; Vitolo MI; Sun Y; Tsokos M; Illei PB; Ladanyi M; Passaniti A; Mackall C; Toretsky JA
    Oncogene; 2003 Apr; 22(15):2334-42. PubMed ID: 12700668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth.
    Huang W; Fridman Y; Bonfil RD; Ustach CV; Conley-LaComb MK; Wiesner C; Saliganan A; Cher ML; Kim HR
    Oncogene; 2012 Oct; 31(42):4527-35. PubMed ID: 22158043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of platelet-derived growth factor-D promotes tumor growth and invasion in endometrial cancer.
    Wang Y; Qiu H; Hu W; Li S; Yu J
    Int J Mol Sci; 2014 Mar; 15(3):4780-94. PubMed ID: 24646915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells.
    Kong D; Banerjee S; Huang W; Li Y; Wang Z; Kim HR; Sarkar FH
    Cancer Res; 2008 Mar; 68(6):1927-34. PubMed ID: 18339874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer.
    Liu J; Liao S; Huang Y; Samuel R; Shi T; Naxerova K; Huang P; Kamoun W; Jain RK; Fukumura D; Xu L
    Clin Cancer Res; 2011 Jun; 17(11):3638-48. PubMed ID: 21459800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer.
    LaRochelle WJ; Jeffers M; Corvalan JR; Jia XC; Feng X; Vanegas S; Vickroy JD; Yang XD; Chen F; Gazit G; Mayotte J; Macaluso J; Rittman B; Wu F; Dhanabal M; Herrmann J; Lichenstein HS
    Cancer Res; 2002 May; 62(9):2468-73. PubMed ID: 11980634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.